Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.IDenta has received a patent for the development of company's new Ecstasy drug detection kit from the US Patent and Trademark Office.
Subscribe to our email newsletter
The IDenta’s Ecstasy kit is said to be the only reliable kit on the market with no false positives and is currently being produced in Israel and marketed in a number of countries throughout the world.
Yaacov Shoham, CEO of IDTA, said: “Process patents such as this one have great value to both our company’s credibility and to the market value of IDenta. This new patent will definitely increase the asset value of IDTA’s balance sheet, thereby directly enhancing shareholder value.”